Fengjie Hao

532 total citations
16 papers, 402 citations indexed

About

Fengjie Hao is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Fengjie Hao has authored 16 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Cancer Research and 6 papers in Epidemiology. Recurrent topics in Fengjie Hao's work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Fengjie Hao is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Fengjie Hao collaborates with scholars based in China, Spain and Germany. Fengjie Hao's co-authors include Francisco Javier Cubero, Junqing Wang, Yulia A. Nevzorova, Xiaochun Fei, Yongjun Chen, Manuel Gómez del Moral, Eduardo Martı́nez-Naves, Teresa Vázquez, Leonard J. Nelson and Santiago Canals and has published in prestigious journals such as Hepatology, Scientific Reports and Journal of Hepatology.

In The Last Decade

Fengjie Hao

15 papers receiving 394 citations

Peers

Fengjie Hao
Michael Pimienta United States
Jinsol Han South Korea
Sen Han China
Faji Yang China
Mi Jeong Heo South Korea
Kristine Villegas United States
Michael Pimienta United States
Fengjie Hao
Citations per year, relative to Fengjie Hao Fengjie Hao (= 1×) peers Michael Pimienta

Countries citing papers authored by Fengjie Hao

Since Specialization
Citations

This map shows the geographic impact of Fengjie Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengjie Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengjie Hao more than expected).

Fields of papers citing papers by Fengjie Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengjie Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengjie Hao. The network helps show where Fengjie Hao may publish in the future.

Co-authorship network of co-authors of Fengjie Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Fengjie Hao. A scholar is included among the top collaborators of Fengjie Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengjie Hao. Fengjie Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Wang, Nan, Simin Guo, Fengjie Hao, et al.. (2022). Pseudogene SNRPFP1 derived long non-coding RNA facilitates hepatocellular carcinoma progress in vitro by sponging tumor-suppressive miR-126-5p. Scientific Reports. 12(1). 21867–21867. 2 indexed citations
5.
Hao, Fengjie, Nan Wang, Yifan Zhang, et al.. (2022). E2F7 enhances hepatocellular carcinoma growth by preserving the SP1/SOX4/Anillin axis via repressing miRNA‐383‐5p transcription. Molecular Carcinogenesis. 61(11). 975–988. 10 indexed citations
6.
Wang, Nan, Fengjie Hao, Yan Shi, & Junqing Wang. (2021). The Controversial Role of Polyploidy in Hepatocellular Carcinoma. OncoTargets and Therapy. Volume 14. 5335–5344. 7 indexed citations
7.
Hao, Fengjie, et al.. (2020). Pseudogene AKR1B10P1 enhances tumorigenicity and regulates epithelial‐mesenchymal transition in hepatocellular carcinoma via stabilizing SOX4. Journal of Cellular and Molecular Medicine. 24(20). 11779–11790. 17 indexed citations
8.
Morán, L. Ortega, Peng Jin, Beatriz Salinas, et al.. (2020). Intestinal Epithelial Cell-Derived Extracellular Vesicles Modulate Hepatic Injury via the Gut-Liver Axis During Acute Alcohol Injury. Frontiers in Pharmacology. 11. 603771–603771. 25 indexed citations
9.
Xu, Wen, Xiaochun Fei, Fengjie Hao, et al.. (2020). Anillin facilitates cell proliferation and induces tumor growth of hepatocellular carcinoma via miR-138/SOX4 axis regulation. Translational Oncology. 13(10). 100815–100815. 17 indexed citations
10.
Wang, Nan, Fengjie Hao, Jiajun Ren, et al.. (2020). Positive feedback loop of AKR1B10P1/miR-138/SOX4 promotes cell growth in hepatocellular carcinoma cells.. PubMed. 12(9). 5465–5480. 9 indexed citations
11.
Hao, Fengjie, Junfeng Shi, Yongjun Chen, Xuefeng Gu, & Di Ma. (2020). Integrated Analysis of a Noncoding RNA-Associated Competing Endogenous RNA Network in Non-Alcoholic Fatty Liver Disease. IEEE Access. 8. 88977–88989. 3 indexed citations
12.
Wang, Junqing, Fengjie Hao, Xiaochun Fei, & Yongjun Chen. (2019). SPP1 functions as an enhancer of cell growth in hepatocellular carcinoma targeted by miR-181c.. PubMed. 11(11). 6924–6937. 45 indexed citations
13.
Hao, Fengjie, Leonard J. Nelson, Teresa Vázquez, et al.. (2018). Alcoholic liver disease: Utility of animal models. World Journal of Gastroenterology. 24(45). 5063–5075. 125 indexed citations
14.
Blaya, Delia, Beatriz Aguilar‐Bravo, Fengjie Hao, et al.. (2018). Expression of microRNA‐155 in inflammatory cells modulates liver injury. Hepatology. 68(2). 691–706. 57 indexed citations
15.
Hao, Fengjie, Francisco Javier Cubero, Pierluigi Ramadori, et al.. (2017). Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice. Cell Death and Disease. 8(10). e3152–e3152. 42 indexed citations
16.
Nevzorova, Yulia A., Francisco Javier Cubero, Wei Hu, et al.. (2015). Enhanced expression of c-myc in hepatocytes promotes initiation and progression of alcoholic liver disease. Journal of Hepatology. 64(3). 628–640. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026